基于片段的药物设计研究进展

郭靖, 陆小云 - 药学进展, 2020 - pps.cpu.edu.cn
基于片段的药物设计(FBDD) 方法是一种通过筛选碎片库得到苗头片段, 然后采用基于结构的
设计策略对苗头片段进行优化和改造获得先导化合物的研究. 其研究过程分为3 个部分: 1) …

Molecular-driven treatment for biliary tract cancer: the promising turning point

M Persano, M Puzzoni, P Ziranu… - Expert Review of …, 2021 - Taylor & Francis
Introduction In the past, targeted therapies have not shown positive results as they have
been used without adequate molecular selection of patients with biliary tract cancer (BTC) …

The Role of Fibroblast Growth Factor-Receptor Pathway Aberrations in Pediatric Diseases

S Bittmann, E Luchter… - Asian Journal of …, 2024 - publish7promo.com
The fibroblast growth factor receptors play a crucial role in binding to fibroblast growth factor
and are involved in various pathological conditions. These receptors consist of an …

[图书][B] Handbook of Targeted Cancer Therapy and Immunotherapy: Gastrointestinal Cancer

M Javle, MJ Borad - 2023 - books.google.com
Designed for quick, everyday reference, Handbook of Targeted Cancer Therapy and
Immunotherapy: Gastrointestinal Cancer provides a practical overview of this rapidly …

Prognostic significance of fibroblast growth factor receptor 4 polymorphisms on biochemical recurrence after radical prostatectomy in a Chinese population

L Chen, Z Lei, X Ma, Q Huang, X Zhang, Y Zhang… - Scientific Reports, 2016 - nature.com
Fibroblast growth factor receptor 4 (FGFR4) is a transmembrane receptor with ligand-
induced tyrosine kinase activity and is involved in various biological and pathological …

Prognostic importance of FGF 2 and FGFR 1 expression for patients affected by ameloblastoma

FP Fonseca, B Monteiro Benites… - Journal of Oral …, 2018 - Wiley Online Library
Background Fibroblast growth factor 2 (FGF 2) and FGF receptor 1 (FGFR 1) have been
investigated in different human neoplasms and were shown to play important roles in the …

Key signaling pathways engaged in cancer management: Current update

S Singh, R Shukla - Current Cancer Therapy Reviews, 2020 - ingentaconnect.com
Background: Till today cancer is still challenging to treat and needs more active therapeutic
approaches. Participation of complex multi-pathway cell propagation instrument is a …

[PDF][PDF] Cząsteczki o potencjale terapeutycznym wiążące FGF1/FGFR1

K Jendryczko, J Chudzian, N Skinde… - Frontiers in …, 2021 - bip.uni.wroc.pl
Czynniki wzrostu fibroblastów (ang. fibroblast growth factors, FGF) oraz ich receptory (ang.
fibroblast growth factor receptor, FGFR) regulują kluczowe procesy zachodzące w …

Design, Synthesis and Biological Evaluation: 5-amino-1H-pyrazole-1-carbonyl derivatives as FGFR Inhibitors

Y Zhang, N Yu - Letters in Drug Design & Discovery, 2020 - ingentaconnect.com
Background: Fibroblast growth factors (FGFs) and their high affinity receptors (FGFRs) play a
major role in cell proliferation, differentiation, migration, and apoptosis. Aberrant FGFR …

US FDA‐Approved Small‐Molecule Kinase Inhibitors for Cancer Therapy

M Yu, S Tadesse, S Wang - Burger's Medicinal Chemistry and …, 2003 - Wiley Online Library
Abnormal activation of kinases is associated with various types of human cancer. A
milestone approval of a small‐molecule kinase inhibitor (SMKI), imatinib, in 2001 for the …